Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL127043 | 0.86 | GABRA1 (0.41) | TAAR1CTBP2GABRA1GABRB2HPGD | |
| SCHEMBL29364508 | 0.86 | GABRA1 (0.41) | TAAR1CTBP2GABRA1GABRB2HPGD | |
| Propane SCHEMBL28338597 | 0.84 | GABRA1 (0.47) | TAAR1CTBP2PTGS1PTGS2GABRA1 | |
| Benzene SCHEMBL28107745 | 0.84 | GABRA1 (0.40) | CTBP2GABRA1GABRB2KEAP1NFE2L2 | |
| SCHEMBL28225610 | 0.84 | GABRA1 (0.40) | GABRA1GABRB2HPGDALDH1A1 | |
| Water SCHEMBL5172983 | 0.84 | GABRA1 (0.40) | GABRA1GABRB2HPGDALDH1A1 | |
| SCHEMBL904507 | 0.83 | GABRA1 (0.42) | TAAR1CTBP2GABRA1GABRB2KEAP1 | |
| Trimethylammonium SCHEMBL28053835 | 0.83 | GABRA1 (0.41) | TAAR1GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL1457269 | 0.83 | GABRA1 (0.50) | GABRA1GABRB2KMT2ATSHRMAPT | |
| SCHEMBL11253674 | 0.82 | TAAR1 (0.48) | TAAR1CTBP2PTGS1PTGS2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022059820-A1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND COMPRISING NON-CHLORINATED DERIVATIVE, AND COMPOSITION OF SAME | 케이에스랩(주) | 2022-03-24 | — | — | WO | claimed |
| CN-113720925-A | Separation detection method of isocyanate derivative | 武汉武药科技有限公司 | 2021-11-30 | — | — | CN | claimed |
| US-20210171451-A1 | DIISOCYANATE COMPOSITION, PREPARATION METHOD THEREOF AND OPTICAL MATERIAL USING SAME | WOORI FINE CHEM CO., LTD. (KR) | 2021-06-10 | — | — | US | claimed |
| EP-3831861-A1 | DIISOCYANATE COMPOSITION, PREPARATION METHOD THEREOF AND OPTICAL MATERIAL USING SAME | SKC Co., Ltd. (KR) | 2021-06-09 | — | — | EP | claimed |
| CN-112920373-A | Diisocyanate composition, method for preparing the same, and optical material using the same | SKC株式会社 | 2021-06-08 | — | — | CN | claimed |
| CN-109725073-A | The method for separating and detecting of acetylcysteine enantiomter | 湖南华纳大药厂科技开发有限公司 | 2019-05-07 | — | — | CN | claimed |
| US-10092881-B2 | Permanent hydrophilic porous coatings and methods of making them | BHA ALTAIR, LLC (US) | 2018-10-09 | — | — | US | claimed |
| US-20130338181-A1 | TREATMENT OF EFFECT OF CHEMICALS WITH THEIR ULTRADILUTE STEREOISOMERS | KUZEFF REINHARD MICHAEL (AU) | 2013-12-19 | — | — | US | claimed |
| US-20090191399-A1 | PERMANENT HYDROPHILIC POROUS COATINGS ONTO A SUBSTRATE AND POROUS MEMBRANES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2009-07-30 | — | — | US | claimed |
| US-20090191398-A1 | MEMBRANES COMPRISING HYDROPHILIC COATINGS | GENERAL ELECTRIC COMPANY (US) | 2009-07-30 | — | — | US | claimed |
| EP-1487448-A4 | TREATMENT OF EFFECT OF CHEMICALS WITH THEIR ULTRADILUTE STEREOISOMERS | SEMPACH PTY LTD (AU) | 2007-04-25 | — | — | EP | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| EP-1487448-A1 | TREATMENT OF EFFECT OF CHEMICALS WITH THEIR ULTRADILUTE STEREOISOMERS | Sempach PTY Ltd (AU) | 2004-12-22 | — | — | EP | claimed |
| WO-2003072105-A1 | TREATMENT OF EFFECT OF CHEMICALS WITH THEIR ULTRADILUTE STEREOISOMERS | SEMPACH PTY LTD (AU) | 2003-09-04 | — | — | WO | claimed |
| EP-0234353-A1 | Process for the production of tetramethyl xylylene diisocyanates | AMERICAN CYANAMID COMPANY (US) | 1987-09-02 | — | — | EP | claimed |
| JP-54138544-A | — | — | None | — | — | JP | disclosed |
| EP-4713378-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-4242122-A | CARBAMOYL-OXY AND -THIO DERIVATIVES OF PHENYLUREA | MONSANTO COMPANY (US) | 1980-12-30 | — | — | US | disclosed |
| JP-S54138544-A | PREPARATION OF ALPHA-METHYLBENZYL ISOCYANATE OR ITS NUCLEAR SUBSTITUTION PRODUCT | SHOWA DENKO KK | 1979-10-27 | — | — | JP | disclosed |
| US-4013450-A | Herbicidal ureido containing carbanilates | MONSANTO COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171451-A1 | DIISOCYANATE COMPOSITION, PREPARATION METHOD THEREOF AND OPTICAL MATERIAL USING SAME | INCENP, IK, ALKBH5 | TAAR1 3913/4885CTBP2 643/4885PTGS1 3821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.